Similarly, analysis of ITGB1 expression using the TIMER database showed overexpression in several cancers, including CHOL, esophageal carcinoma (ESCA), glioblastoma (GBM), KIRC, and LIHC (Figure 3E). Here, ITGB1 is linked to cancer.